Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Glucose in the hypothalamic paraventricular nucleus regulates GLP-1 release
Yue Ma, … , Waljit S. Dhillo, James Gardiner
Yue Ma, … , Waljit S. Dhillo, James Gardiner
Published March 31, 2020
Citation Information: JCI Insight. 2020;5(8):e132760. https://doi.org/10.1172/jci.insight.132760.
View: Text | PDF
Research Article Endocrinology Neuroscience

Glucose in the hypothalamic paraventricular nucleus regulates GLP-1 release

  • Text
  • PDF
Abstract

Glucokinase (GK) is highly expressed in the hypothalamic paraventricular nucleus (PVN); however, its role is currently unknown. We found that GK in the PVN acts as part of a glucose-sensing mechanism within the PVN that regulates glucose homeostasis by controlling glucagon-like peptide 1 (GLP-1) release. GLP-1 is released from enteroendocrine L cells in response to oral glucose. Here we identify a brain mechanism critical to the release of GLP-1 in response to oral glucose. We show that increasing expression of GK or injection of glucose into the PVN increases GLP-1 release in response to oral glucose. On the contrary, decreasing expression of GK or injection of nonmetabolizable glucose into the PVN prevents GLP-1 release. Our results demonstrate that gluco-sensitive GK neurons in the PVN are critical to the response to oral glucose and subsequent release of GLP-1.

Authors

Yue Ma, Risheka Ratnasabapathy, Ivan De Backer, Chioma Izzi-Engbeaya, Marie-Sophie Nguyen-Tu, Joyceline Cuenco, Ben Jones, Christopher D. John, Brian Y.H. Lam, Guy A. Rutter, Giles S.H. Yeo, Waljit S. Dhillo, James Gardiner

×

Figure 1

Effect of genetically increased PVN GK activity on oral glucose tolerance test.

Options: View larger image (or click on image) Download as PowerPoint
Effect of genetically increased PVN GK activity on oral glucose toleranc...
Groups of adult male Wistar rats were injected with either rAAV-GFP (iPVN-GFP) or rAAV-GK (iPVN-GK) bilaterally into the PVN. They then underwent an oral glucose tolerance test (oGTT) and an insulin tolerance test (ITT). (A) GK activity in ARC, VMN, and PVN of iPVN-GFP (shown in green) or iPVN-GK (shown in orange) rats. (B) Plasma glucose during an oGTT. (C) Incremental AUC (iAUC) of 0- to 60-minute plasma glucose during an oGTT. (D) Plasma insulin levels during an oGTT. (E) iAUC of 0- to 60-minute plasma insulin during an oGTT. (F) Plasma glucose levels during an ITT. (G) Plasma GLP-1 levels during an oGTT. (H) iAUC of 0- to 60-minute plasma GLP-1 during an oGTT. Data are represented as mean ± SEM; n = 10 (GFP) and 11 (GK). *P < 0.05, **P < 0.01, and ***P < 0.001. Data for A were analyzed by ANOVA and post hoc Holm-Šídák; data for B, D, F, and G were analyzed by 2-way ANOVA and post hoc Holm-Šídák; data for C, E, and H were analyzed by t test.

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts